<--- Back to Details
First PageDocument Content
Antiretroviral drug / HIV / Tenofovir / AIDS / Viral load / Zidovudine / Gilead Sciences / Resistance Database Initiative / HIV/AIDS / Medicine / Health
Date: 2012-09-28 07:39:30
Antiretroviral drug
HIV
Tenofovir
AIDS
Viral load
Zidovudine
Gilead Sciences
Resistance Database Initiative
HIV/AIDS
Medicine
Health

RDI e-News Issue #2 8th September 2003

Add to Reading List

Source URL: www.hivrdi.org

Download Document from Source Website

File Size: 521,85 KB

Share Document on Facebook

Similar Documents

UNITED STATES of AMERICA  EXPERT HIV HEALTHCARE AHF’s path to becoming the largest provider of HIV/AIDS care in the U.S. began with a small group of dedicated activists in Los Angeles in the 1980s who had a simple

UNITED STATES of AMERICA EXPERT HIV HEALTHCARE AHF’s path to becoming the largest provider of HIV/AIDS care in the U.S. began with a small group of dedicated activists in Los Angeles in the 1980s who had a simple

DocID: 1rhxq - View Document

Principles of collaboration SHCS_NICER_v5-1_NICER__Approved_Nov10

Principles of collaboration SHCS_NICER_v5-1_NICER__Approved_Nov10

DocID: 1r7HF - View Document

June 17, 2009   Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

June 17, 2009  Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

DocID: 1qLnJ - View Document

Title Authors Affiliations

Title Authors Affiliations

DocID: 1qIsB - View Document

Dormant copies of HIV mostly defective, new study shows

Dormant copies of HIV mostly defective, new study shows

DocID: 1qAMy - View Document